Author:
Nieto López de la Nieta Lucía,Guzmán Bernardo Francisco Javier,Castañeda Peñalvo Gregorio,Rodríguez Flores Juana
Funder
Ministerio de Ciencia e Innovación
Gobierno de España Ministerio de Ciencia e Innovación
Subject
Spectroscopy,Analytical Chemistry
Reference20 articles.
1. Tumor Profiling at the Service of Cancer Therapy;Fernandez-Rozadilla;Front. Oncol.,2021
2. Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth;Yakes;Mol. Cancer Ther.,2011
3. VEGF and c-Met blockade amplify angiogenesis inhibition in Pancreatic Islet Cancer;You;Cancer Res.,2011
4. Activity of XL184 (cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer;Kurzrock;J. Clin. Oncol.,2011
5. In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer;Bentzien;Thyroid.,2013
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献